Valore20202021202220232024TTMSpese di vendita, generali e amministrative670.39 M739.37 M874 M917.14 M991.02 M1.05 BRicerca e sviluppo225.28 M253.57 M287.64 M307.52 M331.28 M348.68 MReddito operativo903.68 M1 B1.13 B1.32 B1.69 B1.82 BProventi non operativi, Totale-20.02 M-39.8 M-30.21 M-55.09 M-7.8 M-317 KOneri finanziari, al netto degli interessi capitalizzati23.99 M—————Proventi non operativi, esclusi gli oneri finanziari-58.82 M-43 M-24.5 M-51.6 M-2.54 M13.84 MEntrate/uscite straordinarie14.82 M3.2 M-5.71 M-3.49 M-5.26 M-14.15 MUtile al lordo delle imposte883.66 M960.48 M1.1 B1.26 B1.68 B1.82 BQuota di utile-11.21 M-8.49 M-7.26 M-1.85 M3.64 M4.61 MImposte409.16 M181.05 M204.11 M243.85 M276.84 M332.81 MInteressi di minoranza——————Altri proventi/oneri al netto delle imposte——————Utile netto al lordo delle attività cessate474.5 M779.44 M897.56 M1.02 B1.4 B1.49 BAttività cessate——————Utile netto474.5 M779.44 M897.56 M1.02 B1.4 B1.49 BRegolazione della diluizione——————Dividendi privilegiati——————Utile netto diluito attribuibile agli azionisti ordinari474.5 M779.44 M897.56 M1.02 B1.4 B1.49 BUtile base per azione (EPS base)3.275.346.126.949.5510.15Utile diluito per azione (EPS diluito)3.245.36.096.929.5110.11Numero medio di azioni ordinarie in circolazione145.31 M146.07 M146.76 M147.02 M146.72 M585.46 MAzioni diluite in circolazione146.45 M147.04 M147.46 M147.55 M147.34 M587.83 MEBITDA1.06 B1.14 B1.25 B1.5 B1.88 B2.02 BEBIT903.68 M977.97 M1.08 B1.32 B1.69 B1.82 BCosto del fatturato1.36 B1.55 B1.87 B2.03 B2.09 B2.11 BAltri costi del venduto1.31 B1.51 B1.84 B2 B2.06 B2.08 BAmmortamento e svalutazione (liquidità)156.76 M159.61 M165.16 M176.87 M198.47 M204.89 M
ResMed Inc
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.